M&A Deal Summary |
|
|---|---|
| Date | 2001-10-02 |
| Target | Dupont Pharmaceuticals Company |
| Sector | Life Science |
| Buyer(s) | Bristol-Myers Squibb |
| Sellers(s) | DuPont |
| Deal Type | Divestiture |
| Deal Value | 7.8B USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1887 |
| Sector | Life Science |
| Employees | 34,100 |
| Revenue | 45.0B USD (2023) |
Bristol-Myers Squibb is a life science company engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. The Company's pharmaceutical products include chemically-synthesized drugs, or small molecules, and an increasing portion of products produced from biological processes. The majority of Bristol-Myers Squibb's revenue comes from products in the following therapeutic classes: cardiovascular; virology, including human immunodeficiency virus (HIV) infection; oncology; neuroscience; immunoscience; and metabolics. Bristol-Myers Squibb was incorporated in 1887 and is based in Princeton, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 23 |
| Sector (Life Science) | 1 of 23 |
| Type (Divestiture) | 1 of 1 |
| State (Delaware) | 1 of 1 |
| Country (United States) | 1 of 20 |
| Year (2001) | 1 of 1 |
| Size (of disclosed) | 4 of 19 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2001-08-07 |
Zimmer Biomet Holdings
Warsaw, Indiana, United States Zimmer Biomet Holdings is a designer, developer, manufacturer of orthopaedic reconstructive, spinal and trauma devices, dental implants, and related orthopaedic surgical products. Zimmer Biomet Holdings was founded in 1927 and is based in Warsaw, Indiana. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-09-27 |
Adnexus Therapeutics
Waltham, Massachusetts, United States Adnexus Therapeutics is a developer of a new therapeutic class of biologics called Adnectins. Adnexus Therapeutics was founded in 2002 and is based in Waltham, Massachusetts. |
Buy | $430M |
DuPont is a global chemicals provider and is involved across a range of disciplines, including agriculture and industrial biotechnology, chemistry, biology, materials science and manufacturing. DuPont operates globally and offers a wide range of innovative products and services for markets including agriculture and food, building and construction, electronics and communications, general industrial, and transportation. DuPont is based in Wilmington, Delaware.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 20 |
| Sector (Life Science) | 1 of 2 |
| Type (Divestiture) | 2 of 17 |
| State (Delaware) | 1 of 9 |
| Country (United States) | 3 of 18 |
| Year (2001) | 1 of 1 |
| Size (of disclosed) | 1 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1999-03-16 |
Pioneer Hi-Bred International
Johnston, Iowa, United States Pioneer Hi-Bred International, Inc., we nurture relationships to build mutually successful outcomes by listening to customers, walking their fields and sharing technical resources to develop individualized solutions. Pioneer is working on new traits and using new technologies that will help bring farmers the greatest value and ultimately benefit the entire food and energy value chain. |
Buy | $7.7B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-01-01 |
Solae
St. Louis, Missouri, United States Solae, LLC is a leader in developing soy-based ingredients for nutritious, great-tasting products. Solae provides solutions that deliver a unique combination of functional, nutritional, economical and sustainable benefits to our customers. Headquartered in St. Louis, Missouri, USA, the company was formed through a joint venture between DuPont and Bunge in 2003. |
Buy | - |
